{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:dvt:thrombolysis",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T02:40:00.000Z",
    "contributors": ["vascular-surgery-agent"],
    "status": "validated",
    "confidence": 0.94
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/deep-vein-thrombosis",
    "type": "procedure",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Catheter-Directed Thrombolysis for DVT",
    "definition": "Endovascular technique for treating acute iliofemoral deep vein thrombosis using catheter-delivered thrombolytic agents, with or without pharmacomechanical thrombectomy. Aims to reduce thrombus burden, restore venous patency, preserve valve function, and prevent post-thrombotic syndrome.",
    "clinical_features": {
      "rationale": {
        "goals": [
          "Rapid clot resolution",
          "Preserve venous valve function",
          "Prevent post-thrombotic syndrome (PTS)",
          "Relieve acute symptoms"
        ],
        "pts_prevention": {
          "mechanism": "Anticoagulation alone → clot organization → valve destruction → PTS",
          "incidence_with_ac": "20-50% develop PTS with anticoagulation alone",
          "severe_pts": "5-10% develop severe PTS"
        }
      },
      "patient_selection": {
        "ideal_candidates": {
          "anatomy": "Iliofemoral DVT (proximal)",
          "duration": "Symptom onset <14 days (acute)",
          "symptoms": "Severe symptoms, limb-threatening",
          "life_expectancy": ">1 year",
          "functional_status": "Good baseline function"
        },
        "absolute_contraindications": [
          "Active or recent major bleeding",
          "Recent stroke (<3 months)",
          "Recent major surgery or trauma (<10 days)",
          "Intracranial tumor or AVM",
          "Known bleeding diathesis"
        ],
        "relative_contraindications": [
          "Recent minor surgery",
          "Severe hypertension",
          "Pregnancy (relative)",
          "Age >80 (relative)"
        ]
      },
      "techniques": {
        "catheter_directed_thrombolysis": {
          "access": "Popliteal or posterior tibial vein (ultrasound guided)",
          "catheter": "Multi-sidehole infusion catheter embedded in clot",
          "agents": {
            "tpa": "0.5-1.0 mg/hr",
            "urokinase": "120,000 units/hr (less common now)"
          },
          "duration": "12-48 hours typical",
          "monitoring": "ICU, fibrinogen q6h, PTT"
        },
        "pharmacomechanical_thrombectomy": {
          "definition": "Combines thrombolysis with mechanical disruption",
          "devices": [
            "AngioJet (rheolytic)",
            "EKOS (ultrasound-enhanced)",
            "ClotTriever (mechanical aspiration)",
            "Indigo (aspiration)"
          ],
          "advantages": [
            "Faster clot resolution",
            "Lower lytic dose",
            "Shorter procedure time"
          ]
        }
      },
      "adjunctive_procedures": {
        "iliac_vein_stenting": {
          "indication": "May-Thurner syndrome or residual stenosis",
          "technique": "Self-expanding stent, oversized 1-2mm",
          "timing": "Same session or staged"
        },
        "ivc_filter": {
          "indication": "Contraindication to anticoagulation",
          "type": "Retrievable preferred",
          "retrieval": "Within 30-90 days"
        }
      },
      "outcomes": {
        "attract_trial": {
          "design": "RCT of CDT + anticoagulation vs anticoagulation alone",
          "primary_outcome": "No difference in PTS at 24 months",
          "criticism": ["Included femoropopliteal DVT", "High crossover", "Inconsistent technique"],
          "subgroup": "Possible benefit in iliofemoral-only subgroup"
        },
        "observational_data": {
          "patency": "70-90% at 1 year with stenting",
          "pts_reduction": "Some series show reduced severe PTS"
        }
      },
      "complications": {
        "bleeding": {
          "minor": "Access site hematoma (15-20%)",
          "major": "2-10%",
          "intracranial": "<1%"
        },
        "other": [
          "Pulmonary embolism",
          "Recurrent thrombosis",
          "Access site thrombosis"
        ]
      }
    },
    "diagnostic_codes": {
      "icd10": ["I82.40", "I82.42"],
      "cpt": ["37187", "37188", "37212"]
    }
  },
  "pedagogical": {
    "learning_objectives": [
      "Apply appropriate patient selection criteria for CDT",
      "Compare catheter-directed thrombolysis and pharmacomechanical techniques",
      "Interpret ATTRACT trial results in clinical context"
    ],
    "clinical_pearls": [
      "Symptom duration <14 days and iliofemoral location are key selection criteria",
      "ATTRACT trial didn't show PTS benefit overall, but iliofemoral subgroup may benefit",
      "Pharmacomechanical devices reduce lytic dose and treatment time",
      "Always look for underlying May-Thurner syndrome and stent if present",
      "Check fibrinogen every 6 hours during lytic infusion"
    ],
    "evidence_basis": [
      "ATTRACT Trial (Circulation 2017)",
      "CaVenT Trial (Lancet 2012)"
    ]
  },
  "semantic_relations": {
    "skos:broader": ["vascular:dvt:treatment-overview"],
    "skos:narrower": [
      "vascular:dvt:pharmacomechanical",
      "vascular:dvt:ultrasound-assisted"
    ],
    "skos:related": [
      "vascular:dvt:iliofemoral",
      "vascular:may-thurner:definition",
      "vascular:dvt:pts"
    ]
  }
}
